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Clinical lessons from an elderly man with amiodarone-
induced interstitial lung disease
Brian Rayner
To the Editor: An 82-year-old man was in relatively good 
health despite a background of hypertension, chronic kidney 
disease stage 4 (estimated glomerular filtration rate 15 - 30 
ml/min) and extensive vascular disease requiring carotid 
endartectomy, coronary artery bypass grafting, repair of an 
abdominal aortic aneurysm, and stenting of both renal arteries. 
In May 2005 he developed rapid atrial flutter after an episode 
of acute coronary syndrome. He was successfully cardioverted 
to sinus rhythm. After a loading dose of amiodarone he 
continued on 200 mg daily, and remained in sinus rhythm.
In November 2005 he presented to his GP with symptomatic 
hypotension, lethargy and breathlessness on exertion but no 
orthopnoea or paroxysmal nocturnal dyspnoea. He failed to 
improve despite withdrawal of the antihypertensive treatment. 
He was reviewed by a cardiologist, who made a diagnosis of 
congestive heart failure based on the presence of peripheral 
oedema and inspiratory crackles mainly at the lung bases, and 
a markedly elevated pro-brain natiuretic peptide level of 4 242 
pg/l (normal range < 125 pg/l). His echocardiogram, however, 
showed a reduced but unchanged ejection fraction of 48%. He 
was treated with diuretics, but was admitted to hospital a few 
days later with worsening symptoms of shortness of breath 
and pre-renal failure.
A chest radiograph and high-resolution computed 
tomography (CT) scan (Figs 1 and 2) was misreported as old 
asbestosis instead of acute interstitial lung disease. A previous 
chest radiograph and CT scan done in 1996 are shown for 
comparison (Figs 1 and 2). A repeat echocardiogram showed 
no change in the ejection fraction.
Amiodarone was withdrawn, but the patient continued 
to be managed for cardiac failure and remained critically ill. 
After intervention by the general practitioner, who questioned 
the diagnosis because the patient was more comfortable lying 
flat, the case was reviewed and the diagnosis was changed to 
amiodarone-induced interstitial lung disease. After starting 
high-dose steroids the patient made a slow and steady 
recovery. His shortness of breath improved and the inspiratory 
crackles resolved with clearing of the interstitial changes on 
the chest radiograph. However, even after 1 year of treatment 
he has not returned to his previous baseline activities of daily 
living. 
This case demonstrates a number of important clinical 
lessons.
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Fig. 1. Above: chest radiograph taken in 1996, showing cardiomegaly and 
old asbestos plaque. Below: the current film, showing cardiomegaly and 
interstitial changes mainly at the bases with no signs of cardiac failure.
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1. Drug reactions and toxicity must always be considered 
in the differential diagnosis, especially in elderly patients 
because of altered pharmacokinetics and pharmacodynamics. 
The dosage of many commonly prescribed drugs, including 
amiodarone, often needs to be reduced. 
2. Physicians should always critically review the need for 
ongoing treatment with potentially toxic drugs. 
3. Basic symptoms and signs need to be carefully evaluated.  
Basal crackles can be a sign of both pulmonary oedema and 
interstitial lung disease, and more emphasis should have been 
placed on the lack of orthopnoea – an important symptom of 
left heart failure. 
4. Over-reliance on a single laboratory value can lead to a 
wrong diagnosis. Pro-brain natuiretic peptide is elevated in 
heart failure, but it is not specific. A normal value is a good test 
for excluding heart failure.
5. The review of previous radiological tests is vitally 
important in any case evaluation. 
Finally, the case illustrates many of the problems of clinching 
a diagnosis of amiodarone-induced interstitial lung disease 
in a patient with underlying heart disease, especially if left 
ventricular dysfunction is present.
Fig. 2. Left: this CT scan of the chest was taken in 1996, and is normal. Right: the current scan, showing extensive interstitial changes consistent with a 
drug reaction.
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